Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- Walter Reed National Military Medical Center
- Study ID
- NCT05221021
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Overactive Bladder Syndrome
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Vaginal estrogen — DRUG0.01% estradiol cream 1/2 gram applied vaginally once nightly for two weeks then three times per week with once daily placebo oral pill
- Mirabegron 50 MG [Myrbetriq] — DRUG50mg oral Mirabegron once daily
Study Details
A single site, double-blinded, randomized controlled trial for postmenopausal women with urinary frequency, urgency, nocturia with or without urgency urinary incontinence symptoms. Patient's will be randomized between 0.01% vaginal estradiol cream with placebo oral pill or daily 50 milligrams oral Mirabegron with a placebo vaginal cream for 12 weeks.
Key Dates
- Start date
- Oct 1, 2022
- Status verified
- Aug 2024
- Primary completion
- Dec 30, 2026
- Completion
- Jan 30, 2027
Study Design
- Enrollment
- 152 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Vaginal Estradiol with placebo oral pillPatient will receive 0.01% estradiol cream 1/2 gram applied vaginally once nightly for two weeks then three times per week with once daily placebo oral pill
- Active Comparator: Oral Mirabegron with placebo vaginal creamPatient will receive 50 milligrams oral Mirabegron once daily and placebo vaginal cream (Medisca's VersaPro Cream Base) once nightly for two weeks then three times per week
Primary Outcome Measure
OAB-q short form (SF) symptom bother scores [ Time Frame: 12 weeks ]
Central Contacts
- Christopher W Heuer, DO2626231053
- Katherine L Dengler, MD3522626861
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Walter Reed National Military Medical Center | Bethesda | Maryland | 20889 |
Find similar trials in Bethesda, MD
By research site
Related Studies
- Oxybutynin for Post-surgical Bladder Pain and UrgencyPHASE3 · Recruiting · University of California, Davis · Sacramento, California
- BTL Emsella Chair Versus Sham for the Treatment of Overactive BladderRecruiting · Corewell Health East · Royal Oak, Michigan
- Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder SymptomsPHASE2/PHASE3 · Recruiting · Northwestern University · Chicago, Illinois
- Yoga for Treatment of Overactive Bladder in Pediatric PatientsRecruiting · Duke University · Durham, North Carolina